Social media

Heading to Philadelphia for #ISPORAnnual? Our ICON HEOR and RWE teams will be on-site sharing the latest thinking on patient-centred outcomes, comparative effectiveness research, and innovative evidence synthesis. Let’...

If recruitment and retention matter, site satisfaction must be treated as a prerequisite. In this Journal for Clinical Studies article, Brian Mallon explains why start-up success is shaped by human factors, not technolog...

We’re proud to share that Rose Kidd, President of Operational Delivery at ICON, has been recognised at the Women in Pharma Awards 2026, winning Excellence in senior leadership – life sciences. This award reflects Rose’...

May is Mental Health Awareness Month. More than one in five adults in the US experience mental illness and the average delay between onset of symptoms and treatment is 11 years. Explore ICON’s experience in over 100 ps...

Ankita Minhas will speak on 6 May at OCT Europe in Barcelona at 12:00pm in Stream C. Her session will explore how leading biotechs manage rising complexity through AI-driven innovation, smarter trial designs, and stronge...

Meet the ICON team at SCDM #EMEA26, to discover how we are driving innovation in clinical data science and helping organisations build smarter, more resilient clinical programmes. Visit us at booth 11 to explore how IC...

What is it really like to build a career as a Senior Clinical Research Associate at ICON? In our latest careers blog, Rafi Cabral, MD ,CCRP shares his experience of life as a CRA, from partnering with study sites and su...

Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our free monthly publication b...

Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...

Oligonucleotide (ON) drug development is accelerating rapidly—but first in human (FIH) studies remain complex. Join our upcoming webinar to explore key translational and clinical considerations for initiating FIH antis...

Faster study start up starts with the right sites, and the right tools. Speak with us at ASCO, booth \#35093 to learn about ICON’s purpose built technology suite that helps sponsors identify, activate and collaborate wi...

Great discussion recently at European Pharmaceutical Review’s webinar, “Harnessing AI for more efficient clinical trials.” ICON’s SVP of Enterprise AI, Tony Clarke, joined a panel of industry leaders to share perspectiv...